|
EvoxacDrug - Evoxac The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Cevimeline Hydrochloride
Strength -
EQ 30MG BASE
Applicant -
DAIICHI
New Drug Application (NDA) Number -
020989
Product Number -
002
Therapeutic Equivalence (TE) Code -
Approval Date -
Jan 11, 2000
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Daiichi Medical Research Inc
Evoxac
Zyrtec 5mg Tablet; Oral
Zyrtec-d 12 Hour 5mg;120mg Tablet, Extended Release; Oral Cetrotide Eq 0.25mg Base/ml Injectable; Injection Cetrotide Eq 3mg Base/ml Injectable; Injection Exosurf Neonatal 12mg/vial;108mg/vial;8mg/vial For Suspension; Intratracheal Evoxac Eq 30mg Base Capsule; Oral Zyrtec 5mg/5ml Syrup; Oral Zyrtec 10mg Tablet, Chewable; Oral Zyrtec 5mg Tablet, Chewable; Oral Zyrtec 10mg Tablet; Oral NewDrugInformation |